MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$504,600K
Free Cash flow
$572,800K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Sales or maturities of marketabl...
Net income
Increase in accounts payable, ac...
Others
Negative Cash Flow Breakdown
Purchases of marketable and othe...
Repurchases of common stock
(increase) decrease in accounts ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
1,296,900
727,200
844,600
1,460,000
Depreciation and amortization
123,700
123,200
145,000
136,700
Stock-based compensation expense
243,000
257,400
249,300
237,000
Gains on marketable and other securities, net
61,900
25,000
-21,500
577,700
Other, net
-54,900
-55,600
-136,900
-16,300
Deferred income taxes
194,400
96,000
232,500
278,600
(increase) decrease in accounts receivable
838,500
-1,200
51,200
80,300
Increase in inventories
28,200
-26,600
-2,100
82,600
Increase in prepaid expenses and other assets
319,100
198,600
-82,800
47,900
Increase (decrease) in deferred revenue
43,900
99,600
-3,100
76,600
Increase in accounts payable, accrued expenses, and other liabilities
492,700
107,700
-24,700
759,200
Total adjustments
-483,900
351,700
326,100
158,700
Net cash provided by operating activities
813,000
1,078,900
1,170,700
1,618,700
Purchases of marketable and other securities
1,950,100
2,755,900
2,043,700
3,520,200
Sales or maturities of marketable and other securities
2,148,600
2,606,500
2,555,000
3,365,000
Capital expenditures
240,200
230,600
248,700
201,400
Proceeds from sale of property, plant, and equipment
-
-
0
0
Payments for intangible assets
51,000
48,900
42,000
43,300
Acquisitions, net of cash acquired
-
-
300
3,000
Net cash used in investing activities
-92,700
-428,900
220,300
-402,900
Proceeds from issuance of common stock
49,200
163,100
503,500
40,300
Payments in connection with common stock tendered for employee tax obligations
7,600
73,200
519,200
3,000
Repurchases of common stock
1,169,400
794,300
671,700
664,000
Dividends paid
96,800
97,800
92,700
91,200
Other
0
0
0
0
Net cash used in financing activities
-1,224,600
-802,200
-780,100
-717,900
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
-300
-900
-300
-400
Net decrease in cash, cash equivalents, and restricted cash
-504,600
-153,100
610,600
497,500
Cash, cash equivalents, and restricted cash at beginning of period
2,970,600
3,123,700
3,093,000
3,093,000
Cash, cash equivalents, and restricted cash at end of period
2,466,000
2,970,600
3,123,700
2,513,100
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$1,296,900K
(-6.81%↓ Y/Y)
Net cash provided by
operating activities
$813,000K
(-28.96%↓ Y/Y)
Canceled cashflow
$483,900K
Increase in accounts
payable, accrued...
$492,700K
(127.68%↑ Y/Y)
Stock-based compensation
expense
$243,000K
(-3.46%↓ Y/Y)
Depreciation and
amortization
$123,700K
(-8.44%↓ Y/Y)
Other, net
-$54,900K
(-362.68%↓ Y/Y)
Increase (decrease) in
deferred revenue
$43,900K
(130.72%↑ Y/Y)
Net decrease in
cash, cash...
-$504,600K
(53.17%↑ Y/Y)
Canceled cashflow
$813,000K
Proceeds from issuance of
common stock
$49,200K
(56.19%↑ Y/Y)
Sales or maturities of
marketable and other...
$2,148,600K
(-0.89%↓ Y/Y)
Total adjustments
-$483,900K
(-95.75%↓ Y/Y)
Canceled cashflow
$958,200K
Net cash used in
financing activities
-$1,224,600K
(-8.54%↓ Y/Y)
Canceled cashflow
$49,200K
Net cash used in
investing activities
-$92,700K
(91.53%↑ Y/Y)
Effect of exchange rate
changes on cash, cash...
-$300K
(-175.00%↓ Y/Y)
Canceled cashflow
$2,148,600K
(increase) decrease in
accounts receivable
$838,500K
(2873.40%↑ Y/Y)
Increase in prepaid
expenses and other assets
$319,100K
(38.32%↑ Y/Y)
Deferred income taxes
$194,400K
(43.79%↑ Y/Y)
Gains on marketable
and other...
$61,900K
(-75.24%↓ Y/Y)
Increase in inventories
$28,200K
(-33.65%↓ Y/Y)
Repurchases of common stock
$1,169,400K
(10.16%↑ Y/Y)
Dividends paid
$96,800K
(4.54%↑ Y/Y)
Payments in connection
with common stock...
$7,600K
(35.71%↑ Y/Y)
Purchases of marketable
and other...
$1,950,100K
(-31.70%↓ Y/Y)
Capital expenditures
$240,200K
(9.68%↑ Y/Y)
Payments for intangible
assets
$51,000K
(-72.84%↓ Y/Y)
Buy us a coffee
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
🚨
Price Alert:
The stock price jumped by 13.38% after the earning call.